Advertisement
Screener

INTEGER HOLDINGS CORPORATION (ITGR) Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

2.8 / 5 stars · 68/120 Roast Me

INTEGER HOLDINGS CORPORATION Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

INTEGER HOLDINGS CORPORATION (ITGR) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $23.61 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-04

  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-07-03 was $23.61M, a 36.22% decline year-over-year.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-04-03 was $16.51M.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $48.61M, a 47.42% increase year-over-year.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-26 was $39.68M, a 9.36% increase year-over-year.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $102.83M, a 15.05% decline from fiscal 2024.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $121.05M, a 35.80% increase from fiscal 2023.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $89.14M, a 49.20% increase from fiscal 2022.
  • INTEGER HOLDINGS CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $59.75M, a 35.77% decline from fiscal 2021.
Period endIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2026-07-03$23.61M
10-Q · filed 2026-08-04
$40.11M
10-Q · filed 2026-08-04
$88.72M
derived: sum of 3 quarters · filed 2026-08-04
$128.40M
derived: sum of 4 quarters · filed 2026-08-04
2026-04-03$16.51M
10-Q · filed 2026-04-30
$65.11M
derived: sum of 2 quarters · filed 2026-04-30
$104.79M
derived: sum of 3 quarters · filed 2026-04-30
$141.80M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$48.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
$88.29M
derived: sum of 2 quarters · filed 2026-02-23
$125.30M
derived: sum of 3 quarters · filed 2026-08-04
$102.83M
10-K · filed 2026-02-23
2025-09-26$39.68M
10-Q · filed 2025-10-23
$76.69M
derived: sum of 2 quarters · filed 2026-08-04
$54.22M
10-Q · filed 2025-10-23
$87.19M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-27$37.01M
10-Q · filed 2026-08-04
$14.54M
10-Q · filed 2026-08-04
$47.52M
derived: sum of 3 quarters · filed 2026-08-04
$83.80M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-28-$22.46M
10-Q · filed 2026-04-30
$10.51M
derived: sum of 2 quarters · filed 2026-04-30
$46.79M
derived: sum of 3 quarters · filed 2026-04-30
$78.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$32.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
$69.25M
derived: sum of 2 quarters · filed 2026-02-23
$100.46M
derived: sum of 3 quarters · filed 2026-02-23
$121.05M
10-K · filed 2026-02-23
2024-09-27$36.28M
10-Q · filed 2025-10-23
$67.49M
derived: sum of 2 quarters · filed 2025-10-23
$88.08M
10-Q · filed 2025-10-23
$114.89M
derived: sum of 4 quarters · filed 2026-02-23
2024-06-28$31.21M
10-Q · filed 2025-07-24
$51.80M
10-Q · filed 2025-07-24
$78.61M
derived: sum of 3 quarters · filed 2026-02-23
$106.78M
derived: sum of 4 quarters · filed 2026-02-23
2024-03-29$20.59M
10-Q · filed 2025-04-24
$47.40M
derived: sum of 2 quarters · filed 2026-02-23
$75.58M
derived: sum of 3 quarters · filed 2026-02-23
2023-12-31$26.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
$54.99M
derived: sum of 2 quarters · filed 2026-02-23
$89.14M
10-K · filed 2026-02-23
2023-09-29$28.17M
10-Q · filed 2024-10-24
$62.33M
10-Q · filed 2024-10-24
2022-12-31$59.75M
10-K · filed 2025-02-20
$65.35M
10-K · filed 2023-02-21
2021-12-31$93.02M
10-K · filed 2023-02-21
2020-12-31$15.43M
10-K · filed 2021-02-18
$45.77M
derived: sum of 2 quarters · filed 2021-02-18
$46.16M
derived: sum of 3 quarters · filed 2021-02-18
$77.26M
10-K · filed 2023-02-21
2020-10-02$30.34M
10-K · filed 2021-02-18
$30.73M
derived: sum of 2 quarters · filed 2021-02-18
$61.83M
10-Q · filed 2020-10-29
2020-07-03$389.00K
10-K · filed 2021-02-18
$31.49M
10-Q · filed 2020-07-30
2020-04-04$31.10M
10-K · filed 2021-02-18
2020-04-03$31.10M
10-Q · filed 2020-05-08
$42.14M
derived: sum of 2 quarters · filed 2021-02-18
$72.73M
derived: sum of 3 quarters · filed 2021-02-18
$100.95M
derived: sum of 4 quarters · filed 2021-02-18
2019-12-31$11.04M
10-K · filed 2021-02-18
$41.63M
derived: sum of 2 quarters · filed 2021-02-18
$69.85M
derived: sum of 3 quarters · filed 2021-02-18
$91.22M
10-K · filed 2022-02-22
2019-09-27$30.59M
10-K · filed 2021-02-18
$58.81M
derived: sum of 2 quarters · filed 2021-02-18
$80.17M
10-Q · filed 2020-10-29
$99.37M
derived: sum of 4 quarters · filed 2021-02-18
2019-06-28$28.22M
10-K · filed 2021-02-18
$49.59M
10-Q · filed 2020-07-30
$68.78M
derived: sum of 3 quarters · filed 2021-02-18
$60.48M
derived: sum of 4 quarters · filed 2021-02-18
2019-03-29$21.37M
10-K · filed 2021-02-18
$40.56M
derived: sum of 2 quarters · filed 2021-02-18
$32.26M
derived: sum of 3 quarters · filed 2021-02-18
$55.31M
derived: sum of 4 quarters · filed 2021-02-18
2018-12-28$19.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18
$10.89M
derived: sum of 2 quarters · filed 2021-02-18
$33.95M
derived: sum of 3 quarters · filed 2021-02-18
$47.03M
10-K · filed 2021-02-18
2018-09-28-$8.30M
10-Q · filed 2019-10-31
$14.75M
derived: sum of 2 quarters · filed 2019-10-31
$27.84M
10-Q · filed 2019-10-31
$82.53M
derived: sum of 4 quarters · filed 2020-02-20
2018-06-29$23.06M
10-Q · filed 2019-08-01
$36.14M
10-Q · filed 2019-08-01
$90.84M
derived: sum of 3 quarters · filed 2020-02-20
$110.72M
derived: sum of 4 quarters · filed 2020-02-20
2018-03-30$13.08M
10-Q · filed 2019-05-03
$67.78M
derived: sum of 2 quarters · filed 2020-02-20
$87.66M
derived: sum of 3 quarters · filed 2020-02-20
$97.22M
derived: sum of 4 quarters · filed 2020-02-20
2017-12-29$54.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20
$74.58M
derived: sum of 2 quarters · filed 2020-02-20
$84.14M
derived: sum of 3 quarters · filed 2020-02-20
$87.09M
10-K · filed 2020-02-20
2017-09-29$19.88M
10-Q · filed 2018-11-02
$29.44M
derived: sum of 2 quarters · filed 2018-11-02
$32.39M
10-Q · filed 2018-11-02
2017-06-30$9.56M
10-Q · filed 2018-08-03
$12.51M
10-Q · filed 2018-08-03
2016-12-30$24.88M
10-K · filed 2019-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
LivaNova PLC (LIVN)$4.158B24.01
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53